NEW YORK (TheStreet) -- Shares of Cypress Semiconductor (CY) - Get Cypress Semiconductor Corporation Report and Spansion (CODE) are higher after agreeing to merge, a move TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said is "fantastic." 

Cypress Semiconductor shares climbed 17% Tuesday while Spansion jumped 23.9% on the news. The merger will generate over $100 million in cost savings. Cramer said Cypress Semiconductor is also keeping its 11-cent quarterly dividend payout.

Cypress Semiconductor CEO T.J. Rogers continues to create "tremendous value," Cramer said on CNBC's "Cramer's Mad Dash" segment. "I love him, I love the stock," he added. 

Spansion CODE and Cypress Semiconductor CY data by YCharts

Image placeholder title

TheStreet Recommends

Turning to biotech, he reiterated his bullish stance on Biogen Idec (BIIB) - Get Biogen Inc. Report , calling it a "fabulous" and "inexpensive" company. Regeneron (REGN) - Get Regeneron Pharmaceuticals, Inc. Report , another Cramer favorite, is on its way to $450 per share, he said. 

He also likes Celgene (CELG) - Get Celgene Corporation Report and Gilead Sciences (GILD) - Get Gilead Sciences, Inc. (GILD) Report , but warned investors to be careful of Gilead, at least until AbbVie (ABBV) - Get AbbVie, Inc. Report announces pricing for its hepatitis C treatment. 

-- Written by Bret Kenwell

Follow @BretKenwell

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.